Table 2.

SARS-CoV-2 positivity in rhino-pharyngeal swab and hospital admission in diabetic and nondiabetic subjects by gender and age class, with corresponding rate ratios (RR). ∗p < 0.05; ∗∗p < 0.001.

Classes of age (years)	Population		SARS-CoV-2 Positivity		RR	Hospital admissions		RR
	No diabetes	Diabetes	No diabetes	Diabetes		No diabetes	Diabetes
Women
0–19	423,750	770	338	1	1.63 [0.04–9.13]	12	1	45.9 [1.07–310]∗
20–39	502,751	5208	1647	15	0.88 [0.49–1.45]	80	5	6.03 [1.91–14.7]∗
40–59	763,191	17,726	3583	88	1.06 [0.85–1.31]	385	26	2.91 [1.88–4.33]∗∗
60–69	291,555	22,137	861	96	1.47 [1.18–1.81]∗∗	255	45	2.32 [1.65–3.20]∗∗
70–79	231,259	36,611	822	215	1.65 [1.42–1.92]∗∗	361	111	1.94 [1.56–2.41]∗∗
≥80	192,849	38,537	2599	638	1.23 [1.12–1.34]∗∗	864	254	1.47 [1.27–1.69]∗∗
Men
0–19	449,919	815	321	1	1.72 [0.04–9.65]	6	0	–
20–39	521,306	2887	1328	14	1.90 [1.04–3.21]∗	88	3	6.16 [1.25–18.6]∗
40–59	756,376	29,501	2549	143	1.44 [1.21–1.70]∗∗	683	63	2.36 [1.80–3.06]∗∗
60–69	257,673	39,074	1081	226	1.38 [1.19–1.59]∗∗	531	145	1.80 [1.49–2.17]∗∗
70–79	183,379	47,645	857	330	1.48 [1.30–1.68]∗∗	497	224	1.73 [1.47–2.04]∗∗
≥80	107,231	28,919	1065	340	1.18 [1.04–1.34]∗	627	235	1.39 [1.19–1.62]∗∗